APO RESEARCH · REPORT
Clinical Trial Imaging
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Product & engineering
Understand the product.
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Selected research
Market Structure
Global Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
According to the Segmentation of types, all the market of Clinical Trial Imaging can be divided into In-house Imaging Service and Central Imaging Service. The Central Imaging Service, it holds a comparatively larger share in global market, which accounts for about 69% in 2019.
Based on the Clinical Trial Imaging application, the Clinical Trial Imaging market is sub-segmented into several major Application, like Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others, etc. Pharmaceutical Companies and Biotechnology Companies are the most important applications, which holds nearly 1/3 and 1/4 of the market in 2019.
Read the full market overview
From the view of region, North America and Europe have a larger market share in 2019 which account for about 1/3 and 27%, and will witness a stable growth in following years. Asia-Pacific and India hold a big market share also, and they will witness the comparatively bigger market share in the future.
The world TOP 5 players in the Clinical Trial Imaging market are ICON, ERT, McLaren, Bioclinica, Parexel. These Top 5 companies currently account for more than 43% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Report Includes
This report provides an overview of the global Clinical Trial Imaging market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Clinical Trial Imaging and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Clinical Trial Imaging revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Clinical Trial Imaging market size, projected growth trends, production technologies, key applications, and end-use industries.
Clinical Trial Imaging Segment by Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Clinical Trial Imaging Segment by Type
In-house Imaging Service
Central Imaging Service
Clinical Trial Imaging Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Clinical Trial Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Clinical Trial Imaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trial Imaging industry.
Chapter 3: Detailed analysis of Clinical Trial Imaging companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Imagingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In-house Imaging Service
- Central Imaging Service
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
Companies covered
- ICON
- ERT
- McLaren
- Bioclinica
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Clinical Trial Imaging Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 In-house Imaging Service
- 1.2.3 Central Imaging Service
- 1.3 Market Analysis by Application
- 1.3.1 Global Clinical Trial Imaging Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnology Companies
- 1.3.4 Academic Institutes
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Clinical Trial Imaging Growth Trends by Region
- 1.5.1 Global Clinical Trial Imaging Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Clinical Trial Imaging Market Size by Region (2021-2026)
- 1.5.3 Clinical Trial Imaging Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Clinical Trial Imaging Market Dynamics
- 2.1 Clinical Trial Imaging Industry Trends
- 2.2 Clinical Trial Imaging Industry Drivers
- 2.3 Clinical Trial Imaging Industry Opportunities and Challenges
- 2.4 Clinical Trial Imaging Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Clinical Trial Imaging Revenue by Company (2021-2026)
- 3.2 Global Clinical Trial Imaging Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Clinical Trial Imaging Key Company Head office and Area Served
- 3.4 Global Clinical Trial Imaging Company, Product Type & Application
- 3.5 Global Clinical Trial Imaging Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Clinical Trial Imaging Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Clinical Trial Imaging Players Market Share by Revenue in 2025
- 3.6.3 2025 Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
4 Clinical Trial Imaging Market by Type
- 4.1 Global Clinical Trial Imaging Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Clinical Trial Imaging Market Size by Type (2021-2032)
- 4.3 Global Clinical Trial Imaging Market Size Share by Type (2021-2032)
5 Clinical Trial Imaging Market by Application
- 5.1 Global Clinical Trial Imaging Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Clinical Trial Imaging Market Size by Application (2021-2032)
- 5.3 Global Clinical Trial Imaging Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 ICON
- 6.1.1 ICON Company Information
- 6.1.2 ICON Business Overview
- 6.1.3 ICON Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 ICON Clinical Trial Imaging Product Portfolio
- 6.1.5 ICON Recent Developments
- 6.2 ERT
- 6.2.1 ERT Company Information
- 6.2.2 ERT Business Overview
- 6.2.3 ERT Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 ERT Clinical Trial Imaging Product Portfolio
- 6.2.5 ERT Recent Developments
- 6.3 McLaren
- 6.3.1 McLaren Company Information
- 6.3.2 McLaren Business Overview
- 6.3.3 McLaren Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 McLaren Clinical Trial Imaging Product Portfolio
- 6.3.5 McLaren Recent Developments
- 6.4 Bioclinica
- 6.4.1 Bioclinica Company Information
- 6.4.2 Bioclinica Business Overview
- 6.4.3 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
- 6.4.5 Bioclinica Recent Developments
- 6.5 Parexel
- 6.5.1 Parexel Company Information
- 6.5.2 Parexel Business Overview
- 6.5.3 Parexel Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Parexel Clinical Trial Imaging Product Portfolio
- 6.5.5 Parexel Recent Developments
- 6.6 BioTelemetry
- 6.6.1 BioTelemetry Company Information
- 6.6.2 BioTelemetry Business Overview
- 6.6.3 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
- 6.6.5 BioTelemetry Recent Developments
- 6.7 ProScan Imaging
- 6.7.1 ProScan Imaging Company Information
- 6.7.2 ProScan Imaging Business Overview
- 6.7.3 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
- 6.7.5 ProScan Imaging Recent Developments
- 6.8 Imaging Endpoints
- 6.8.1 Imaging Endpoints Company Information
- 6.8.2 Imaging Endpoints Business Overview
- 6.8.3 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
- 6.8.5 Imaging Endpoints Recent Developments
- 6.9 Radiant Sage
- 6.9.1 Radiant Sage Company Information
- 6.9.2 Radiant Sage Business Overview
- 6.9.3 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
- 6.9.5 Radiant Sage Recent Developments
- 6.10 Micron, Inc.
- 6.10.1 Micron, Inc. Company Information
- 6.10.2 Micron, Inc. Business Overview
- 6.10.3 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
- 6.10.5 Micron, Inc. Recent Developments
- 6.11 Intrinsic Imaging
- 6.11.1 Intrinsic Imaging Company Information
- 6.11.2 Intrinsic Imaging Business Overview
- 6.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
- 6.11.5 Intrinsic Imaging Recent Developments
- 6.12 Median Technologies
- 6.12.1 Median Technologies Company Information
- 6.12.2 Median Technologies Business Overview
- 6.12.3 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
- 6.12.5 Median Technologies Recent Developments
- 6.13 Cardiovascular Imaging Technologies
- 6.13.1 Cardiovascular Imaging Technologies Company Information
- 6.13.2 Cardiovascular Imaging Technologies Business Overview
- 6.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
- 6.13.5 Cardiovascular Imaging Technologies Recent Developments
- 6.14 Banook Medical
- 6.14.1 Banook Medical Company Information
- 6.14.2 Banook Medical Business Overview
- 6.14.3 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
- 6.14.5 Banook Medical Recent Developments
- 6.15 IXICO
- 6.15.1 IXICO Company Information
- 6.15.2 IXICO Business Overview
- 6.15.3 IXICO Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 IXICO Clinical Trial Imaging Product Portfolio
- 6.15.5 IXICO Recent Developments
7 North America
- 7.1 North America Clinical Trial Imaging Market Size (2021-2032)
- 7.2 North America Clinical Trial Imaging Market Size by Type
- 7.2.1 North America Clinical Trial Imaging Market Size by Type (2021-2026)
- 7.2.2 North America Clinical Trial Imaging Market Size by Type (2027-2032)
- 7.2.3 North America Clinical Trial Imaging Market Share by Type (2021-2032)
- 7.3 North America Clinical Trial Imaging Market Size by Application
- 7.3.1 North America Clinical Trial Imaging Market Size by Application (2021-2026)
- 7.3.2 North America Clinical Trial Imaging Market Size by Application (2027-2032)
- 7.3.3 North America Clinical Trial Imaging Market Share by Application (2021-2032)
- 7.4 North America Clinical Trial Imaging Market Size by Country
- 7.4.1 North America Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Clinical Trial Imaging Market Size by Country (2021-2026)
- 7.4.3 North America Clinical Trial Imaging Market Size by Country (2027-2032)
- 7.4.4 North America Clinical Trial Imaging Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Imaging Market Size (2021-2032)
- 8.2 Europe Clinical Trial Imaging Market Size by Type
- 8.2.1 Europe Clinical Trial Imaging Market Size by Type (2021-2026)
- 8.2.2 Europe Clinical Trial Imaging Market Size by Type (2027-2032)
- 8.2.3 Europe Clinical Trial Imaging Market Share by Type (2021-2032)
- 8.3 Europe Clinical Trial Imaging Market Size by Application
- 8.3.1 Europe Clinical Trial Imaging Market Size by Application (2021-2026)
- 8.3.2 Europe Clinical Trial Imaging Market Size by Application (2027-2032)
- 8.3.3 Europe Clinical Trial Imaging Market Share by Application (2021-2032)
- 8.4 Europe Clinical Trial Imaging Market Size by Country
- 8.4.1 Europe Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Clinical Trial Imaging Market Size by Country (2021-2026)
- 8.4.3 Europe Clinical Trial Imaging Market Size by Country (2027-2032)
- 8.4.4 Europe Clinical Trial Imaging Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Clinical Trial Imaging Market Size (2021-2032)
- 9.2 China Clinical Trial Imaging Market Size by Type
- 9.2.1 China Clinical Trial Imaging Market Size by Type (2021-2026)
- 9.2.2 China Clinical Trial Imaging Market Size by Type (2027-2032)
- 9.2.3 China Clinical Trial Imaging Market Share by Type (2021-2032)
- 9.3 China Clinical Trial Imaging Market Size by Application
- 9.3.1 China Clinical Trial Imaging Market Size by Application (2021-2026)
- 9.3.2 China Clinical Trial Imaging Market Size by Application (2027-2032)
- 9.3.3 China Clinical Trial Imaging Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Clinical Trial Imaging Market Size (2021-2032)
- 10.2 Asia Clinical Trial Imaging Market Size by Type
- 10.2.1 Asia Clinical Trial Imaging Market Size by Type (2021-2026)
- 10.2.2 Asia Clinical Trial Imaging Market Size by Type (2027-2032)
- 10.2.3 Asia Clinical Trial Imaging Market Share by Type (2021-2032)
- 10.3 Asia Clinical Trial Imaging Market Size by Application
- 10.3.1 Asia Clinical Trial Imaging Market Size by Application (2021-2026)
- 10.3.2 Asia Clinical Trial Imaging Market Size by Application (2027-2032)
- 10.3.3 Asia Clinical Trial Imaging Market Share by Application (2021-2032)
- 10.4 Asia Clinical Trial Imaging Market Size by Country
- 10.4.1 Asia Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Clinical Trial Imaging Market Size by Country (2021-2026)
- 10.4.3 Asia Clinical Trial Imaging Market Size by Country (2027-2032)
- 10.4.4 Asia Clinical Trial Imaging Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Clinical Trial Imaging Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Clinical Trial Imaging Market Size by Type
- 11.2.1 South America, Middle East & Africa Clinical Trial Imaging Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Clinical Trial Imaging Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Clinical Trial Imaging Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Clinical Trial Imaging Market Size by Application
- 11.3.1 South America, Middle East & Africa Clinical Trial Imaging Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Clinical Trial Imaging Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Clinical Trial Imaging Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Clinical Trial Imaging Market Size by Country
- 11.4.1 South America, Middle East & Africa Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Clinical Trial Imaging Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Clinical Trial Imaging Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Clinical Trial Imaging Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst